Therapeutic peptides

Details for Australian Patent Application No. 2005232437 (hide)

Owner The University of Bristol

Inventors Virji, Mumtaz

Agent Davies Collison Cave

Pub. Number AU-B-2005232437

PCT Pub. Number WO2005/099337

Priority 0419594.7 03.09.04 GB; 0408390.3 15.04.04 GB

Filing date 15 April 2005

Wipo publication date 27 October 2005

Acceptance publication date 6 October 2011

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

C07K 14/21 (2006.01) Peptides having more than 20 amino acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/099337 Priority application(s): WO2005/099337

6 October 2011 Application Accepted

  Published as AU-B-2005232437

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005232441-Liquids containing suspended glass particles

2005232436-Annexin V for preventing atherothrombois and plaque rupture